Status:
COMPLETED
Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients
Lead Sponsor:
Toujinkai Hospital
Conditions:
Acute Myocardial Infarction
Congestive Heart Failure
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
Survival after invasive coronary revascularization is worse in patients with chronic kidney disease than in those without it. The investigators aimed to examine whether oral administration of nicorand...
Eligibility Criteria
Inclusion
- Hemodialysis patients with coronary artery disease who had undergone a successful first PCI with bare-metal stents between July 1, 2001 and December 31, 2003.
Exclusion
- Subjects with moderate or worse cardiac valvular disease or old myocardial infarction at the point of first PCI.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00848562
Start Date
January 1 2002
End Date
December 1 2006
Last Update
February 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toujinkai Hospital
Kyoto, Kyoto, Japan, 612-8026